Treatment Action Group (TAG) is profoundly disappointed and outraged at the lack of healthcare protections for people living with and affected by HIV, tuberculosis (TB), and hepatitis C (HCV) in the bill to end the US government shutdown.
TAG’s annual Research in Action Awards is our most anticipated night of the year.
We’re proud to partner with Vivid Coffee, a Vermont-based specialty roastery and café, on the creation of the T.A.G. Blend.
TAG letter urging the Advisory Committee on Immunization Practices (ACIP) to maintain the recommendation of a universal hepatitis B virus (HBV) birth dose vaccine in the United States.
On Sept. 3 20+ organizations — including TAG — signed this Infectious Diseases Society of America’s (IDSA) joint statement calling for the resignation of Sec. Robert F. Kennedy Jr. The letter outlines the many ways Kennedy’s “agenda” is meant to undermine science and public health.
Matthew Leifheit is an American photographer, magazine editor, and professor based in Brooklyn, New York. A graduate of Rhode Island School of Design and the Yale School of Art, Leifheit is Editor-in-Chief of MATTE Magazine, the journal of emerging photography…
The current administration’s Executive Order on Ending Crime and Disorder on America’s streets is yet another direct attack on science and basic human rights.
Treatment Action Group (TAG) opposes in the strongest possible terms the suspension of at least 22 TB research awards by the National Institutes of Health (NIH) following a May 2025 White House executive order banning “gain-of-function” research.
TAG is organizing this webinar on July 29 for community organizations and advocates to raise awareness about the HCV Elimination bill, and prepare them to meet and engage with their Senators during the August recess in their district offices or Town Hall meetings.
TAG was among thirteen organizations that cosponsored this Congressional briefing held on July 9, 2025. Briefing materials and presentations are available for download.